Overview

Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to evaluate the efficacy (effectiveness) and safety of olanzapine in treating pathological gambling.
Phase:
Phase 3
Details
Lead Sponsor:
Lindner Center of HOPE
Collaborators:
Eli Lilly and Company
University of Cincinnati
Treatments:
Olanzapine